Humacyte, Inc.HUMANASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
127.82%
↑ 296% above average
Average (23q)
-65.32%
Historical baseline
Range
High:299.45%
Low:-891.29%
Volatility
-1823.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 127.82% |
| Q2 2025 | -21.20% |
| Q1 2025 | -140.45% |
| Q4 2024 | 299.45% |
| Q3 2024 | 0.60% |
| Q2 2024 | -1.79% |
| Q1 2024 | 46.98% |
| Q4 2023 | -156.88% |
| Q3 2023 | 93.60% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | -641.91% |
| Q3 2022 | 84.90% |
| Q2 2022 | -634.38% |
| Q1 2022 | 88.69% |
| Q4 2021 | -6.13% |
| Q3 2021 | -9.13% |
| Q2 2021 | -891.29% |
| Q1 2021 | 89.29% |
| Q4 2020 | 5.10% |
| Q3 2020 | -18.52% |
| Q2 2020 | 17.61% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |